US Stock MarketDetailed Quotes

NRTSF Nobilis Health Corp.

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose May 9 16:00 ET
78.25Market Cap0.00P/E (TTM)

Nobilis Health Corp. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2018
(Q1)Mar 31, 2018
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
(Q3)Sep 30, 2017
(Q2)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-97.33%63K
2.67M
26.39M
-1.49M
8.99M
2.36M
Net income from continuing operations
-46.54%1.74M
---3.14M
--10.28M
--9.23M
--1K
--3.26M
Operating gains losses
-192.34%-217K
--122K
---324K
---100K
---145K
--235K
Depreciation and amortization
85.47%5.21M
--4.73M
--11.6M
--3.57M
--2.81M
--2.81M
Deferred tax
-88.57%223K
---982K
--11.7M
--11.92M
---335K
--1.95M
Other non cash items
166.13%330K
--340K
---2.98M
---2.55M
---662K
--124K
Change In working capital
-10.33%-7.04M
---265K
---10.5M
---27.39M
--6.18M
---6.38M
-Change in receivables
-21.06%-9.31M
--10.13M
---14.74M
---28.03M
---1.98M
---7.69M
-Change in inventory
-118.07%-90K
--210K
--1.41M
--132K
---25K
--498K
-Change in prepaid assets
422.00%644K
---656K
---4.04M
---806K
---522K
---200K
-Change in payables and accrued expense
2,155.00%902K
---7.3M
--5.01M
--1.13M
--9.01M
--40K
-Change in other current liabilities
-19.15%878K
---2.54M
--2.4M
--368K
---248K
--1.09M
-Change in other working capital
43.86%-64K
---110K
---540K
---185K
---52K
---114K
Cash from discontinued investing activities
Operating cash flow
-97.33%63K
--2.67M
--26.39M
---1.49M
--8.99M
--2.36M
Investing cash flow
Cash flow from continuing investing activities
-46.62%-434K
-619K
-67.42M
-54.15M
-1.58M
-296K
Net PPE purchase and sale
-135.47%-697K
---619K
---5.15M
---682K
---668K
---296K
Net business purchase and sale
--263K
--0
---62.27M
---53.47M
---915K
--0
Cash from discontinued investing activities
Investing cash flow
-46.62%-434K
---619K
---67.42M
---54.15M
---1.58M
---296K
Financing cash flow
Cash flow from continuing financing activities
-58.15%-6.34M
-1.34M
38.99M
44.04M
-2.49M
-4.01M
Net issuance payments of debt
71.49%-1.05M
--3.21M
--46.52M
--48.58M
---1.49M
---3.69M
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
Net other financing activities
-1,551.88%-5.29M
---4.55M
---7.53M
---4.54M
---998K
---320K
Cash from discontinued financing activities
Financing cash flow
-58.15%-6.34M
---1.34M
--38.99M
--44.04M
---2.49M
---4.01M
Net cash flow
Beginning cash position
-25.43%23.24M
--22.54M
--24.57M
--34.14M
--29.23M
--31.17M
Current changes in cash
-245.60%-6.71M
--703K
---2.04M
---11.6M
--4.91M
---1.94M
End cash Position
-43.44%16.53M
--23.24M
--22.54M
--22.54M
--34.14M
--29.23M
Free cash flow
-130.69%-634K
--2.02M
--21.24M
---2.18M
--8.32M
--2.07M
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
(Q2)Jun 30, 2018(Q1)Mar 31, 2018(FY)Dec 31, 2017(Q4)Dec 31, 2017(Q3)Sep 30, 2017(Q2)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -97.33%63K2.67M26.39M-1.49M8.99M2.36M
Net income from continuing operations -46.54%1.74M---3.14M--10.28M--9.23M--1K--3.26M
Operating gains losses -192.34%-217K--122K---324K---100K---145K--235K
Depreciation and amortization 85.47%5.21M--4.73M--11.6M--3.57M--2.81M--2.81M
Deferred tax -88.57%223K---982K--11.7M--11.92M---335K--1.95M
Other non cash items 166.13%330K--340K---2.98M---2.55M---662K--124K
Change In working capital -10.33%-7.04M---265K---10.5M---27.39M--6.18M---6.38M
-Change in receivables -21.06%-9.31M--10.13M---14.74M---28.03M---1.98M---7.69M
-Change in inventory -118.07%-90K--210K--1.41M--132K---25K--498K
-Change in prepaid assets 422.00%644K---656K---4.04M---806K---522K---200K
-Change in payables and accrued expense 2,155.00%902K---7.3M--5.01M--1.13M--9.01M--40K
-Change in other current liabilities -19.15%878K---2.54M--2.4M--368K---248K--1.09M
-Change in other working capital 43.86%-64K---110K---540K---185K---52K---114K
Cash from discontinued investing activities
Operating cash flow -97.33%63K--2.67M--26.39M---1.49M--8.99M--2.36M
Investing cash flow
Cash flow from continuing investing activities -46.62%-434K-619K-67.42M-54.15M-1.58M-296K
Net PPE purchase and sale -135.47%-697K---619K---5.15M---682K---668K---296K
Net business purchase and sale --263K--0---62.27M---53.47M---915K--0
Cash from discontinued investing activities
Investing cash flow -46.62%-434K---619K---67.42M---54.15M---1.58M---296K
Financing cash flow
Cash flow from continuing financing activities -58.15%-6.34M-1.34M38.99M44.04M-2.49M-4.01M
Net issuance payments of debt 71.49%-1.05M--3.21M--46.52M--48.58M---1.49M---3.69M
Proceeds from stock option exercised by employees ----------0--0--------
Net other financing activities -1,551.88%-5.29M---4.55M---7.53M---4.54M---998K---320K
Cash from discontinued financing activities
Financing cash flow -58.15%-6.34M---1.34M--38.99M--44.04M---2.49M---4.01M
Net cash flow
Beginning cash position -25.43%23.24M--22.54M--24.57M--34.14M--29.23M--31.17M
Current changes in cash -245.60%-6.71M--703K---2.04M---11.6M--4.91M---1.94M
End cash Position -43.44%16.53M--23.24M--22.54M--22.54M--34.14M--29.23M
Free cash flow -130.69%-634K--2.02M--21.24M---2.18M--8.32M--2.07M
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg